NCT07144085View on ClinicalTrials.gov

Application of ⁶⁸Ga-FXX489 (NNS309) PET/CT Imaging in Diagnosis of Tumor Diseases.

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

July 31, 2027

Study Completion Date

July 31, 2027

Conditions
TumorMetastatic Cancer
Interventions
DRUG

68Ga-FXX489

The dose will be 3 to 8 millicurie (mCi) +/- 10% given intravenously at a single time prior to imaging.

PROCEDURE

Positron Emission Tomography (PET) imaging

Participants will be scanned for approximately 30 to 45 minutes.

DRUG

Gallium-68 labelled (68Ga-) FAP-2286

The dose will be 3 to 8 millicurie (mCi) +/- 10% given intravenously at a single time prior to imaging.

Trial Locations (1)

110001

The First Hospital of China Medical University, Shenyang

All Listed Sponsors
lead

Yi Tian

OTHER